HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alberti, G. Articles by Silink, M. Search for Related Content PubMed PubMed Citation Articles by Alberti, G. Articles by Silink, M. Social Bookmarking                What's this?

Type 2 Diabetes in the Young: The Evolving Epidemic

The International Diabetes Federation Consensus Workshop

Address correspondence and reprint requests to Dr. Jonathan Shaw, MD, MRCP(UK), FRACP, Director of Research, International Diabetes Institute, 250 Kooyong Rd., Caulfield, Victoria 3162, Australia. E-mail: jshaw@idi.org.au

Abbreviations: ADA, American Diabetes Association • CVD, cardiovascular disease • DKA, diabetic ketoacidosis • IDF, International Diabetes Federation • HNF, hepatocyte nuclear factor • IFG, impaired fasting glucose • IGT, impaired glucose tolerance • MODY, maturity-onset diabetes of youth • OGTT, oral glucose tolerance test • PCOS, polycystic ovary syndrome

The first 300 words of the full text of this article appear below.

	EXECUTIVE SUMMARY

 

1. The aims of the consensus meeting were to review the epidemiology, pathophysiology, management, and implications of the rising prevalence of type 2 diabetes in young people and to suggest means by which the continuing rise in incidence and prevalence might be prevented.
   
2. The overall global prevalence of type 2 diabetes is rising steadily. Previously, type 2 diabetes was predominantly a disease of middle-aged and older people. In recent decades, the age of onset has decreased and type 2 diabetes has been reported in adolescents and children worldwide, particularly in high-prevalence populations. Japan has seen an approximate fourfold rise in the incidence of type 2 diabetes in 6- to 15-year-olds, and between 8 and 45% of newly presenting children and adolescents in the U.S. have type 2 diabetes. The problem is particularly noticeable in indigenous peoples. Population-based data, however, are sparse and indeed absent in most countries.
   
3. Additional cardiovascular risk factors are often associated with type 2 diabetes in the young, and microangiopathy is as common or commoner in those developing type 2 diabetes at a young age as in those with type 1 diabetes. This has profound societal implications.
   
4. Diagnostic separation of type 2 from other types of diabetes in young people can be difficult, and sophisticated testing may be necessary.
   
5. Data on the pathophysiology in the young are sparse, but there is no evidence to suggest differences from adults. The incidence of type 2 in the young is rising in parallel with the incidence of overweight and obesity, suggesting a possible causal relationship, particularly when the obesity is central and in relation to decreased physical activity. Other factors include family history, gestational diabetes in the mother, and low birth weight. All of these are associated with insulin resistance, although decreased insulin secretion is also required.
   
6. Mass screening for type . . . [Full Text of this Article]

	RECOMMENDATIONS

	AIM AND OBJECTIVES OF THE WORKSHOP

	INTRODUCTION AND BACKGROUND

	EPIDEMIOLOGY

	CLASSIFICATION AND DIAGNOSIS

	PATHOGENESIS

	SCREENING

	TREATMENT

-Glucosidase inhibitors.

	PREVENTION

	CONCLUSIONS

	APPENDIX: WORKSHOP PARTICIPANTS

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. M. Cowell Focus on Diagnosis: Type 2 Diabetes Mellitus Pediatr. Rev., August 1, 2008; 29(8): 289 - 292. [Full Text] [PDF]

				J C. Agwu Screening for type 2 diabetes mellitus in children and adolescents The British Journal of Diabetes & Vascular Disease, July 1, 2008; 8(4): 163 - 168. [Abstract] [PDF]

				K. A. Matyka Type 2 diabetes in childhood: epidemiological and clinical aspects Br. Med. Bull., June 1, 2008; 86(1): 59 - 75. [Abstract] [Full Text] [PDF]

				L. Terre Behavioral Medicine Review: Weight Control in a Land of Milk and Honey American Journal of Lifestyle Medicine, December 1, 2007; 1(6): 447 - 450. [Abstract] [PDF]

				L. M. Bell, K. Watts, A. Siafarikas, A. Thompson, N. Ratnam, M. Bulsara, J. Finn, G. O'Driscoll, D. J. Green, T. W. Jones, et al. Exercise Alone Reduces Insulin Resistance in Obese Children Independently of Changes in Body Composition J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4230 - 4235. [Abstract] [Full Text] [PDF]

				L. Terre Behavioral Medicine Review: Strategic Management of Diabetes Risk American Journal of Lifestyle Medicine, October 1, 2007; 1(5): 351 - 355. [Abstract] [PDF]

				S. F. E. Praet and L. J. C. van Loon Optimizing the therapeutic benefits of exercise in Type 2 diabetes J Appl Physiol, October 1, 2007; 103(4): 1113 - 1120. [Abstract] [Full Text] [PDF]

				S. Snitker, K. Y. Le, E. Hager, B. Caballero, and M. M. Black Association of Physical Activity and Body Composition With Insulin Sensitivity in a Community Sample of Adolescents Arch Pediatr Adolesc Med, July 1, 2007; 161(7): 677 - 683. [Abstract] [Full Text] [PDF]

				S. G. Anand, S. D. Mehta, and W. G. Adams Diabetes Mellitus Screening in Pediatric Primary Care Pediatrics, November 1, 2006; 118(5): 1888 - 1895. [Abstract] [Full Text] [PDF]

				M. E. Pavkov, P. H. Bennett, W. C. Knowler, J. Krakoff, M. L. Sievers, and R. G. Nelson Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA, July 26, 2006; 296(4): 421 - 426. [Abstract] [Full Text] [PDF]

				M. C. Eppens, M. E. Craig, J. Cusumano, S. Hing, A. K.F. Chan, N. J. Howard, M. Silink, and K. C. Donaghue Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes. Diabetes Care, June 1, 2006; 29(6): 1300 - 1306. [Abstract] [Full Text] [PDF]

				G. Florvall, S. Basu, J. Helmersson, and A. Larsson Hemocue Urine Albumin Point-Of-Care Test Shows Strong Agreement With the Results Obtained With a Large Nephelometer Diabetes Care, February 1, 2006; 29(2): 422 - 423. [Full Text] [PDF]

				P. M. Thule, A. G. Campbell, D. J. Kleinhenz, D. E. Olson, J. J. Boutwell, R. L. Sutliff, and C. M. Hart Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E114 - E122. [Abstract] [Full Text] [PDF]